Seeing Is Believing
Healthcare - Sector
CRSP is currently covered by 16 analysts with an average price target of $67.85. This is a potential upside of $13.59 (25.05%) from yesterday's end of day stock price of $54.26.
Crispr Therapeutics AG's activity chart (see below) currently has 437 price targets and 344 ratings on display. The stock rating distribution of CRSP is 78.79% BUY, 18.18% HOLD and 3.03% SELL.
Analysts average stock forecasts to be materialized ratio is 64.47% with an average time for these price targets to be met of 102.32 days.
Highest price target for CRSP is $110, Lowest price target is $6, average price target is $67.85.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 31-Aug-2026. First documented stock forecast 14-Nov-2016.
Currently out of the existing stock ratings of CRSP, 26 are a BUY (78.79%), 6 are a HOLD (18.18%), 1 are a SELL (3.03%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Feb-2022
$82
$32.61 (66.03%)
$82
1 months 29 days ago
(31-Aug-2026)
8/30 (26.67%)
$25.02 (43.91%)
214
Buy Since 12-Nov-2019
$80
$30.61 (61.98%)
$80
1 months 29 days ago
(31-Aug-2026)
13/30 (43.33%)
$23.02 (40.40%)
159
Buy Since 18-Apr-2024
$88
$38.61 (78.17%)
$82
2 months 26 days ago
(04-Aug-2026)
11/21 (52.38%)
$34.93 (65.82%)
145
Buy Since 03-Feb-2025
$80
$30.61 (61.98%)
$80
3 months 22 days ago
(08-Jul-2026)
5/9 (55.56%)
$20.8 (35.14%)
82
Hold Since 11-Jun-2026
$60
$5.08 (9.25%)
$32
4 months 19 days ago
(11-Jun-2026)
8/9 (88.89%)
$9.77 (19.45%)
254
What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?
Which analyst most recently updated their price target on CRSP (Crispr Therapeutics AG)?
Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?